For citations:
Shamalov NA, Khasanova DR, Marchenko SV, Soldatov MA, Alekseeva TP, Androfagina OV, Antipova LN, Anishchenko LI, Beketova EM, Bulanov AA, Gerasimova AV, Gorst NK, Gutsalyuk AG, Demin TV, Dyudin AV, Yelemanov UA, Zakaryaeva AR, Zinovyeva NN, Ziborova SS, Kazakov DN, Komissarova NV, Korobeynikov IV, Korovashkova KV, Kuzmin EL, Kulesh AA, Kuliev RR, Lebedev AS, Lukyanov AL, Maksimov VI, Mikhaylenko OI, Moldavskaya IV, Murtazalieva DM, Mukhamadieva YS, Nesterova VN, Novikov DG, Platunova SV, Prudius EP, Rayemgulov RA, Saskin VA, Sinelshchikova AV, Strautmanis EA, Suryakhin VS, Tavlueva EV, Telyatnik YA, Halo NV, Cherepyansky MS, Marskaya NA. Thrombolytic therapy with Revelisa in ischemic stroke: results of the PRIMA international multicenter observational study. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2025;17(1):57-66. (In Russ.) https://doi.org/10.14412/2074-2711-2025-1-57-66